Mars, Incorporated to Acquire Heska Corporation

Heska Corporation Acquires Lacuna Diagnostics

January 13, 2021

Healthcare Services

Heska Corporation announced an agreement to acquire 100% of Lacuna Diagnostics, a Fort Collins–based developer of point-of-care digital cytology and telemedicine pathology services for the veterinary market. The acquisition gives Heska immediate specialty clinical services capabilities — including a digital telemedicine cytology platform and an expert network of pathologists — and is intended to expand Heska's product and revenue streams to better serve veterinary customers.

Heska Corporation Acquires Biotech Laboratories U.S.A. LLC to Enter Rapid Assay Veterinary Diagnostics Market

September 1, 2021

Medical Devices

Heska Corporation acquired majority ownership of Biotech Laboratories U.S.A. LLC, a Rockville, Maryland developer of rapid point-of-care lateral flow diagnostics for animals. The acquisition (closed Sept. 1, 2021) brings Biotech's rapid assay pipeline, manufacturing expertise and IP into Heska's product portfolio as the company moves to launch a full line of single-use rapid assays for veterinarians and livestock producers.

Mars Acquires Cerba HealthCare's Stake in Cerba Vet and ANTAGENE

July 2, 2024

Healthcare Services

Mars, Incorporated has completed its acquisition of Cerba HealthCare's ownership stake in French veterinary diagnostics businesses Cerba Vet and ANTAGENE. The two businesses will join Mars Petcare's Science & Diagnostics division to complement its existing veterinary diagnostics and genetic testing capabilities.

Mars, Incorporated to Acquire Kellanova (Financed with $26 Billion Senior Notes)

March 5, 2025

Consumer Products

Mars, Incorporated priced a previously announced private offering of $26.0 billion of senior notes. The company said it intends to use the net proceeds, along with other financing sources and cash on hand, to fund its pending acquisition of Kellanova, subject to customary closing conditions and regulatory approvals.

Veterinary Pharmaceutical Solutions Acquires Diamond Animal Health

January 18, 2024

Veterinary

Veterinary Pharmaceutical Solutions (VPS), a Granite Creek Capital Partners portfolio company, acquired Diamond Animal Health from Mars Corporation. Granite Creek supported the deal with a follow-on investment from its FlexCap II fund, creating an integrated animal health platform combining VPS's compounding capabilities with Diamond's contract manufacturing and vaccine production.

Mars Completes Acquisition of Kellanova

December 11, 2025

Food & Beverage

Mars, Incorporated completed its acquisition of Kellanova, bringing together Mars’ snacking portfolio with Kellanova’s billion-dollar brands such as Pringles, Cheez-It and Pop-Tarts. The transaction was announced in August 2024 and received the remaining regulatory approvals by December 8, 2025.